Anavex Life Sciences Corp (AVXL)

[falconer66a]

Yes, but FDA does read journal articles.

NDA at the FDA is all that matters. Wall Street isnt reading medical journals to pick stocks.

Quite so. But the FDA does read peer-reviewed journal articles. Such an article substantiating blarcamesine's safety and efficacy will prompt the FDA's approval of Anavex's New Drug Application (which Anavex is probably writing right now). When the journal article appears, the NDA will be promptly conveyed to the FDA. Newspapers and media outlets will be reporting on the article. The New York Times, reluctantly, may have an article title, "New Drug Shown to Stop or Reverse Alzheimer's."